6-bromoindirubin-3'-oxime,
6BIO cpd,
667463-62-9,
BIO,
GSK-3 Inhibitor IX,
6-bromoindirubin-3-oxime,
6-BROMOINDIRUBIN-3'-OXIME,
6BIO,
6-BIO,
(2'Z,3'E)-6-Bromoindirubin-3'-oxime,
GSK 3 Inhibitor IX,
GSK-3 Inhibitor IX (BIO),
CHEBI:86290,
MFCD08705318,
(2Z,3E)-6-Bromoindirubin-3'-oxime,
InSolution™ GSK-3 Inhibitor IX,
(3E)-6'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-OXIME,
BRW,
C16H10BrN3O2,
(2′Z,3′E)-6-Bromoindirubin-3′-oxime,
(2Z,3E)-6'-bromo-2,3'-biindole-2',3(1H,1'H)-dione 3-oxime,
(3Z)-6-bromo-3-[3-(hydroxyamino)indol-2-ylidene]-1H-indol-2-one,
AC1NRAET,
1uv5,
6-bromo-indirubin-3'oxime,
GSK 3 IX,
BIO; 6-BIO,
6-bromoindirubin-3''-oxime,
2H-Indol-2-one, 6-bromo-3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-, (3Z)-,
MLS001074886,
SCHEMBL470802,
CHEMBL355496,
GTPL5974,
SCHEMBL4997980,
SCHEMBL8246737,
CHEMBL2178734,
SCHEMBL14088703,
SCHEMBL15565919,
CHEBI:91343,
CTK8E9656,
AOB4191,
DTXSID60648023,
EX-A689,
HMS2230G20,
HMS3229G18,
HMS3262K08,
HMS3265E19,
HMS3265E20,
HMS3265F19,
HMS3265F20,
HMS3374K01,
HMS3648C22,
HMS3653G17,
HMS3677H16,
BCP07234,
BIO, >=98% (HPLC),
Tox21_500773,
2268AH,
BDBM50012188,
BDBM50191406,
GL6265,
HSCI1_000232,
IN1314,
NSC737347,
NSC745931,
s7198,
ZINC18128386,
ZINC18128389,
AKOS024457468,
AKOS026750263,
AKOS030238964,
AKOS032947350,
ZINC100469404,
ZINC100493712,
CCG-101292,
CCG-208082,
CS-3360,
DB03444,
LP00773,
NSC-737347,
NSC-745931,
NCGC00094112-01,
NCGC00094112-02,
NCGC00094112-03,
NCGC00094112-04,
NCGC00094112-06,
NCGC00261458-01,
4CA-0280,
AK176375,
AN-27620,
BC600306,
HY-10580,
SMR000568408,
B4006,
SW219792-1,
KS-00001549,
K00001,
MLS-0388607.0001,
SR-01000838093,
SR-01000838093-3,
6-bromo-3-[3-(hydroxyamino)indol-2-ylidene]indolin-2-one,
(Z)-6'-Bromo-1H,1'H-[2,3']biindolylidene-3,2'-dione 3-oxime,
(2E,3E)-6'-bromo-3-(hydroxyimino)-[2,3'-biindolinylidene]-2'-one,
(2Z,3E)-6'-Bromo-3-(hydroxyimino)-[2,3'-biindolinylidene]-2'-one,
(3Z)-6-Bromo-3-[(3E)-3-hydroxyimino-1H-indol-2-ylidene]-1H-indol-2-one,
(3Z)-6-bromo-3-[(3E)-3-hydroxyiminoindolin-2-ylidene]indolin-2-one,
(Z)-6''-Bromo-1H,1''H-[2,3'']biindolylidene-3,2''-dione 3-oxime,
6-bromo-3-[(3E)-3-(hydroxyimino)-1H-indol-2-ylidene]-1H-indol-2-one,
6-Bromo-3-[3-(hydroxyamino)-2H-indol-2-ylidene]-1,3-dihydro-2H-indol-2-one,
6-bromo-3-[3-(hydroxyamino)-2H-indol-2-ylidene]-2,3-dihydro-1H-indol-2-one,
6-Bromo-3-[3-(hydroxyimino)-1,3-dihydro-2H-indol-2-ylidene]-1,3-dihydro-2H-indol-2-one,
(2 inverted exclamation mark Z,3 inverted exclamation mark E)-6-Bromoindirubin-3 inverted exclamation marka-oxime,
(3Z)-6-bromo-3-[(3E)-3-(hydroxyimino)-1,3-dihydro-2H-indol-2-ylidene]-1,3-dihydro-2H-indol-2-one,
2H-Indol-2-one,6-bromo-3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-,(3Z)-,
indirubin deriv. 7a,
6BIO cpd,
D06OAH,
D0P3XL,
6-Bromo-indirubin-3/'oxime,
CHEMBL243555,
CHEMBL409450,
6-bromoindirubin-3'-oxime (BIO),
ACN-025783,
BIO, 98% - 10MG 10mg,
CID5287844,
CID11405589,
B1538,
C483321,
2H-Indol-2-one, 6-broMo-3-[(3E)-1,3-dihydro-3-(hydroxyiMino)-2H-indol-2-ylidene]-1,3-dihydro-,,
SDS
COA
